联赢激光(688518) - 2023 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2023 was ¥854,226,909.59, a decrease of 5.87% compared to the same period last year[5]. - The net profit attributable to shareholders for Q3 2023 was ¥53,508,015.40, down 54.33% year-on-year[5]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥46,213,601.59, a decrease of 58.55% compared to the previous year[5]. - Basic and diluted earnings per share for Q3 2023 were both ¥0.16, reflecting a decline of 58.97% year-on-year[6]. - Total revenue for the first three quarters of 2023 reached ¥2,554,656,701.39, a 35% increase from ¥1,894,199,806.56 in the same period of 2022[19]. - Operating costs for the first three quarters of 2023 were ¥2,323,548,710.50, up from ¥1,704,341,066.79 in 2022, reflecting a significant increase in operational expenses[21]. - The company's operating profit for the first three quarters of 2023 was ¥287,128,418.82, compared to ¥217,703,587.34 in the previous year, showing improved profitability[21]. - The total profit for Q3 2023 was CNY 287,835,187.20, compared to CNY 218,664,480.07 in Q3 2022, indicating an increase of 31.7%[22]. Research and Development - Research and development expenses for Q3 2023 totaled ¥47,904,308.05, an increase of 45.11% compared to the same period last year[6]. - Research and development expenses increased to ¥153,553,615.03 in 2023 from ¥85,137,746.48 in 2022, indicating a focus on innovation and product development[21]. - The company plans to continue increasing its investment in research and development to drive future growth[10]. Assets and Liabilities - The total assets at the end of Q3 2023 were ¥6,965,710,281.11, representing a 23.04% increase from the end of the previous year[6]. - Non-current assets totaled ¥895,860,788.72, an increase from ¥831,018,171.35 in the previous year, indicating growth in long-term investments[17]. - Total current assets reached ¥6,069,849,492.39, a significant rise from ¥4,830,200,447.25, marking an increase of 25.7%[15]. - Current liabilities decreased to ¥3,967,467,638.21 from ¥3,865,331,727.26, suggesting improved liquidity management[17]. - Total liabilities reached approximately 3.88 billion, with current liabilities comprising about 3.87 billion, reflecting a high level of short-term obligations[31]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 14,316[12]. - The top shareholder, Han Jinlong, holds 28,624,356 shares, representing 8.45% of total shares[12]. - The second-largest shareholder, Niu Zengqiang, owns 12,826,646 shares, accounting for 3.79%[12]. - The company has a total of 10 major shareholders, with the top 3 holding a combined 14.57% of shares[12]. Cash Flow - The company reported a cash flow from operating activities of -¥14,054,506.12 for the year-to-date[6]. - Cash flow from operating activities for the first nine months of 2023 was CNY 1,891,533,017.88, compared to CNY 1,395,484,344.48 in the same period of 2022, indicating a growth of 35.6%[25]. - The net cash flow from operating activities for Q3 2023 was CNY -14,054,506.12, an improvement from CNY -155,390,497.19 in Q3 2022[26]. - The net cash flow from investing activities for the first nine months of 2023 was CNY -276,728,933.86, a decrease from CNY 96,765,113.00 in the same period last year[26]. - The net cash flow from financing activities for the first nine months of 2023 was CNY 904,740,837.29, significantly higher than CNY 64,889,554.30 in the same period of 2022[26]. Inventory and Receivables - Accounts receivable increased to ¥1,380,930,020.57 from ¥1,065,543,003.31, reflecting a growth of 29.6% year-over-year[15]. - Inventory as of September 30, 2023, stands at ¥2,752,020,990.97, compared to ¥2,608,471,773.53 at the end of 2022, indicating an increase of 5.5%[15]. Financial Health - The equity attributable to shareholders at the end of Q3 2023 was ¥2,983,121,524.26, up 67.60% from the end of the previous year[6]. - The company's equity attributable to shareholders increased to ¥2,983,121,524.26 from ¥1,779,934,251.04, indicating stronger financial health[17]. - The company maintains a strong position with a capital reserve of approximately 824.23 million, supporting future growth initiatives[31]. Audit and Compliance - There are no applicable audit opinions for the financial statements as of September 30, 2023[15]. - The company has not disclosed any significant new product developments or market expansion strategies in the current report[14].